Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend.

Tytuł:: Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend.
Autorzy:: Groves S; School of Health Sciences, Manchester Centre for Health Psychology, Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
McCutchan G; Wales Cancer Research Centre, Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.
Quaife SL; Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Murray RL; Academic Unit of Lifespan and Population Health, Faculty of Medicine, University of Nottingham, Nottingham, UK.
Ostroff JS; Memorial Sloan-Kettering Cancer Center, Behavioral Sciences Service, New York, New York, USA.
Brain K; Wales Cancer Research Centre, Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.
Crosbie PAJ; LydiaBecker Institute of Immunology and Inflammation, Division of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester, Wythenshawe, UK.
Yorke J; School of Health Sciences, Manchester Centre for Health Psychology, Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Christie Patient-Centred Research, Division of Nursing, Midwifery and Social Work, The Christie NHS Foundation Trust, The University of Manchester, Manchester, UK.
Baldwin D; Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Field JK; Institute of Systems, Molecular and Integrative Biology, Molecular and Clinical Cancer Medicine, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
McWilliams L; School of Health Sciences, Manchester Centre for Health Psychology, Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Źródło:: Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2022 Aug; Vol. 25 (4), pp. 1703-1716. Date of Electronic Publication: 2022 May 05.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Original Publication: Oxford, UK : Wiley, c1998-
MeSH Terms:: Attitude to Health*
Early Detection of Cancer*/psychology
Lung Neoplasms*/diagnosis
Lung Neoplasms*/prevention & control
Lung Neoplasms*/psychology
Smoking Cessation*/psychology
Aged ; Aged, 80 and over ; Attitude ; Focus Groups ; Humans ; Middle Aged ; Motivation ; Qualitative Research ; United Kingdom
References:: Health Expect. 2020 Apr;23(2):433-441. (PMID: 31961060)
J Thorac Oncol. 2018 Aug;13(8):1062-1075. (PMID: 29800746)
Health Expect. 2017 Aug;20(4):563-573. (PMID: 27397651)
J Epidemiol Community Health. 2021 Oct;75(10):1001-1009. (PMID: 33883199)
Thorax. 2016 Feb;71(2):161-70. (PMID: 26645413)
Ann Transl Med. 2016 Apr;4(8):157. (PMID: 27195275)
BMC Public Health. 2020 Oct 6;20(1):1512. (PMID: 33023537)
BMJ Open. 2020 Sep 10;10(9):e037086. (PMID: 32912948)
JAMA Intern Med. 2015 Sep;175(9):1530-7. (PMID: 26214612)
N Engl J Med. 2011 Aug 4;365(5):395-409. (PMID: 21714641)
Lung Cancer. 2007 Apr;56(1):125-34. (PMID: 17196298)
Curr Oncol. 2021 Mar 14;28(2):1197-1203. (PMID: 33799451)
Transl Lung Cancer Res. 2021 Feb;10(2):1099-1109. (PMID: 33718048)
CA Cancer J Clin. 2021 Jul;71(4):299-314. (PMID: 34015860)
BMC Med Res Methodol. 2013 Sep 18;13:117. (PMID: 24047204)
Health Expect. 2022 Aug;25(4):1703-1716. (PMID: 35514094)
J Cancer Educ. 2018 Oct;33(5):1120-1125. (PMID: 28405898)
BMJ Open Respir Res. 2019 Nov 24;6(1):e000448. (PMID: 31803474)
Nicotine Tob Res. 2020 Aug 24;22(9):1484-1491. (PMID: 31504798)
J Thorac Oncol. 2011 Nov;6(11):1841-8. (PMID: 21892105)
Br J Health Psychol. 2021 Dec 1;:. (PMID: 34852182)
Am J Respir Crit Care Med. 2020 Apr 15;201(8):965-975. (PMID: 31825647)
Ann Intern Med. 2021 Sep;174(9):1232-1239. (PMID: 34310171)
Thorax. 2012 May;67(5):418-25. (PMID: 22106018)
Lancet Oncol. 2017 Dec;18(12):e754-e766. (PMID: 29208441)
Transl Behav Med. 2018 Mar 1;8(2):243-267. (PMID: 29447386)
Thorax. 2020 Oct;75(10):908-912. (PMID: 32759387)
BJGP Open. 2020 Aug 25;4(3):. (PMID: 32522753)
Thorax. 2017 Oct;72(10):912-918. (PMID: 28710339)
Cancer. 2022 May 15;128(10):1976-1986. (PMID: 35143041)
Nicotine Tob Res. 2020 Aug 24;22(9):1476-1483. (PMID: 31418449)
J Natl Cancer Inst. 2014 May 28;106(6):dju122. (PMID: 24872542)
J Natl Cancer Inst. 2014 May 28;106(6):dju084. (PMID: 24872540)
Lung Cancer. 2019 Apr;130:121-127. (PMID: 30885332)
BMC Public Health. 2006 Dec 11;6:300. (PMID: 17156479)
Nat Rev Clin Oncol. 2021 Mar;18(3):135-151. (PMID: 33046839)
Implement Sci. 2017 Jun 21;12(1):77. (PMID: 28637486)
Health Expect. 2018 Dec;21(6):1150-1158. (PMID: 30085384)
BMJ Open. 2019 Nov 2;9(11):e032727. (PMID: 31678956)
Nicotine Tob Res. 2020 Mar 16;22(3):431-439. (PMID: 30476209)
Int J Environ Res Public Health. 2018 Feb 17;15(2):. (PMID: 29462994)
Lung Cancer. 2020 Jan;139:41-46. (PMID: 31726252)
Health Expect. 2017 Feb;20(1):59-68. (PMID: 26701339)
Lancet Oncol. 2014 Nov;15(12):1342-50. (PMID: 25282284)
PLoS One. 2013 Aug 07;8(8):e71379. (PMID: 23940744)
BMC Health Serv Res. 2021 May 20;21(1):481. (PMID: 34016109)
BMJ Open. 2019 May 22;9(5):e025902. (PMID: 31122972)
Lung Cancer. 2019 Aug;134:66-71. (PMID: 31319997)
J Thorac Oncol. 2021 Dec;16(12):2016-2028. (PMID: 34403828)
Contemp Clin Trials. 2021 Jul;106:106429. (PMID: 33964415)
Implement Sci. 2012 Apr 24;7:37. (PMID: 22530986)
Lung Cancer. 2019 Feb;128:1-5. (PMID: 30642439)
Public Health. 2021 May;194:216-222. (PMID: 33962099)
Thorax. 2019 Apr;74(4):405-409. (PMID: 29440588)
Health Expect. 2019 Apr;22(2):162-172. (PMID: 30289583)
BMJ. 2017 Dec 28;359:j5742. (PMID: 29284594)
BMJ Open Respir Res. 2022 Feb;9(1):. (PMID: 35121633)
Chest. 2020 Sep;158(3):1250-1259. (PMID: 32304776)
Br J Cancer. 2011 Dec 6;105 Suppl 2:S77-81. (PMID: 22158327)
Thorax. 2019 Dec;74(12):1176-1178. (PMID: 31481631)
Grant Information:: 24460 United Kingdom CRUK_ Cancer Research UK; P30 CA008748 United States CA NCI NIH HHS; A27905 United Kingdom CRUK_ Cancer Research UK
Contributed Indexing:: Keywords: cancer prevention; lung cancer; lung cancer screening; qualitative; smoking cessation
Entry Date(s):: Date Created: 20220506 Date Completed: 20220729 Latest Revision: 20240210
Update Code:: 20240210
PubMed Central ID:: PMC9327806
DOI:: 10.1111/hex.13513
PMID:: 35514094
: Czasopismo naukowe

Pełny tekst

Introduction: There is limited research exploring how smoking cessation treatment should be implemented into lung cancer screening in the United Kingdom. This study aimed to understand attitudes and preferences regarding the integration of smoking cessation support within lung cancer screening from the perspective of those eligible.
Methods: Thirty-one lung cancer screening eligible individuals aged 55-80 years with current or former smoking histories were recruited using community outreach and social media. Two focus groups (three participants each) and 25 individual telephone interviews were conducted. Data were analysed using the framework approach to thematic analysis.
Results: Three themes were generated: (1) bringing lung cancer closer to home, where screening was viewed as providing an opportunity to motivate smoking cessation, depending on perceived personal risk and screening result; (2) a sensitive approach to cessation with the uptake of cessation support considered to be largely dependent on screening practitioners' communication style and expectations of stigma and (3) creating an equitable service that focuses on ease of access as a key determinant of uptake, where integrating cessation within the screening appointment may sustain increased quit motivation and prevent loss to follow-up.
Conclusions: The integration of smoking cessation into lung cancer screening was viewed positively by those eligible to attend. Screening appointments providing personalized lung health information may increase cessation motivation. Services should proactively support participants with possible fatalistic views regarding risk and decreased cessation motivation upon receiving a good screening result. To increase engagement in cessation, services need to be person-centred.
Patient or Public Contribution: This study has included patient and public involvement throughout, including input regarding study design, research materials, recruitment strategies and research summaries.
(© 2022 The Authors. Health Expectations published by John Wiley & Sons Ltd.)

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja